Brain

Every post on brain, newest first.

Posts

StudiesOct 23, 20265 min read
New semaglutide research spans mood, kidney, and fat regain
Three recent reports add detail to semaglutide beyond weight loss: a depression trial measured choices, a kidney safety analysis compared kidney function levels, and a mouse study followed fat tissue after stopping.

Compound pages

The evergreen research summaries these posts build on.

SemaglutideLong-acting GLP-1 receptor agonist for diabetes and weight management.LiraglutideA once-daily GLP-1 injection approved for weight loss and diabetes.DulaglutideOnce-weekly GLP-1 agonist for type 2 diabetes and heart-risk reduction.CagrilintideOnce-weekly investigational amylin analogue for weight management.ExenatideA GLP-1 receptor agonist studied for diabetes and weight.